Formal FDA meetings that this playbook focuses on

Updated on Apr 24, 2025
Published on Aug 1, 2023

1 minute(s) read

For this playbook, we are focusing on the INTERACT, Pre-IND, and IND submissions and meeting types.

Flowchart depicting the phases of a playbook. It starts with "Preclinical" and progresses through "Clinical Trials" (Phase 1, Phase 2, Phase 3), "Marketing Application," and ends with "Post-marketing." Each phase is represented by an arrow pointing to the next phase. Below these arrows are boxes indicating specific meetings or activities: "INTERACT Meeting," "Pre-IND Meeting," "End of Phase 1 Meeting," "End of Phase 2 Meeting," and two instances of "Pre-BLA Meeting." — Schematic representing focus of the playbook

Was this article helpful?